| Aug 13, 2026 | Citigroup | Tyler Radke | PT Raise | Neutral | $7→$9 |
| Aug 13, 2026 | Barclays | Raimo Lenschow | PT Raise | Overweight | $5→$11 |
| Aug 12, 2026 | Northland Capital Markets | Luke Horton | Upgrade | Market Perform→Outperform | $5→$10 |
| Aug 5, 2026 | Oppenheimer | Ken Wong | PT Raise | Outperform | $7→$9 |
| Jul 9, 2026 | Citigroup | Tyler Radke | PT Raise | Neutral | $3→$7 |
| Jun 18, 2026 | Oppenheimer | Ken Wong | PT Raise | Outperform | $4→$7 |
| Apr 21, 2026 | Barclays | Raimo Lenschow | PT Cut | Overweight | $7→$5 |
| Apr 10, 2026 | Citigroup | Tyler Radke | Downgrade | Buy→Neutral | $9→$3 |
| Feb 20, 2026 | Citigroup | Tyler Radke | PT Cut | Buy | $11→$9 |
| Feb 19, 2026 | Oppenheimer | Ken Wong | PT Cut | Outperform | $7→$4 |
| Feb 19, 2026 | Needham | Scott Berg | Downgrade | Buy→Hold | — |
| Feb 18, 2026 | William Blair | Bhavan Suri | Downgrade | Outperform→Market Perform | — |
| Feb 18, 2026 | Citizens | Patrick Walravens | Downgrade | Market Outperform→Market Perform | — |
| Feb 4, 2026 | Oppenheimer | Ken Wong | PT Cut | Outperform | $10→$7 |
| Jan 12, 2026 | Barclays | Raimo Lenschow | PT Cut | Overweight | $12→$10 |
| Dec 17, 2025 | Oppenheimer | Ken Wong | PT Cut | Outperform | $12→$10 |
| Nov 17, 2025 | Needham | Scott Berg | Maintained | Buy | $14 |
| Aug 18, 2025 | Oppenheimer | Ken Wong | PT Raise | Outperform | $13→$14 |
| Aug 1, 2025 | Citigroup | Tyler Radke | PT Cut | Buy | $13→$11 |
| May 15, 2025 | Barclays | Raimo Lenschow | PT Cut | Overweight | $15→$10 |
